From 2009.igem.org
(Difference between revisions)
|
|
Line 209: |
Line 209: |
| <br> | | <br> |
| <div class="heading"> | | <div class="heading"> |
- | Descriptive Title of What You're Doing
| + | Colony PCR for Verification of J13002-LuxOD47E-B0015 Construction |
| </div> | | </div> |
| <br> | | <br> |
| <div class="desc"> | | <div class="desc"> |
| </html> | | </html> |
- | WIKI CODING HERE
| + | *Performed a colony PCR of J13002-LuxOD47E-B0015 to see if the B0015 terminator was seuccessfully cloned in, using BBK-CP forward and reverse primers and p Taq. Cycling conditions were the same as used for the last Colony PCR (see July 9th 2009 for details). PCR products were visualized on a 1% agarose gel and run with Generuler 1 kb+ DNA ladder along with J13002-LuxOD47E and LuxOD47E as size controls. See photo of gel below. |
| + | |
| + | *Analysis: Lanes 1-4 are J13002-LuxOD47E-B0015 trial 1 (treating B0015 as the Insert). Lanes 5-8 are trial 2 (treating J13002-LuxOD47E as the Insert). Lane 9 is J13002-LuxOD47E (a size control), Lane 10 is LuxOD47E BBK (another size control) and Lane 11 is a negative control. |
| + | |
| + | *This gel seems ot be kind of slanted, which isn't very good for size comparison. It looks like some of the first lanes of Trial 1 may have worked (contain the B0015 terminator) as they appear slighlty higher than other lanes, however we will run a new gel with the PCR product to be sure. |
| + | |
| + | CODING HERE |
| | | |
| <html> | | <html> |
Revision as of 20:01, 20 August 2009
University of Calgary
|
CAROL
Descriptive Title of What You’re Doing
WIKI CODING HERE
|
|
CHINMOYEE
Looked at Markov Models ( Part of Optimization)
|
|
EMILY
Colony PCR for Verification of J13002-LuxOD47E-B0015 Construction
- Performed a colony PCR of J13002-LuxOD47E-B0015 to see if the B0015 terminator was seuccessfully cloned in, using BBK-CP forward and reverse primers and p Taq. Cycling conditions were the same as used for the last Colony PCR (see July 9th 2009 for details). PCR products were visualized on a 1% agarose gel and run with Generuler 1 kb+ DNA ladder along with J13002-LuxOD47E and LuxOD47E as size controls. See photo of gel below.
- Analysis: Lanes 1-4 are J13002-LuxOD47E-B0015 trial 1 (treating B0015 as the Insert). Lanes 5-8 are trial 2 (treating J13002-LuxOD47E as the Insert). Lane 9 is J13002-LuxOD47E (a size control), Lane 10 is LuxOD47E BBK (another size control) and Lane 11 is a negative control.
- This gel seems ot be kind of slanted, which isn't very good for size comparison. It looks like some of the first lanes of Trial 1 may have worked (contain the B0015 terminator) as they appear slighlty higher than other lanes, however we will run a new gel with the PCR product to be sure.
CODING HERE
|
|
FAHD
Descriptive Title of What You're Doing
|
|
IMAN
Descriptive Title of What You're Doing
|
|
JAMIE
Descriptive Title of What You're Doing
|
|
JEREMY
Descriptive Title of What You're Doing
|
|
KATIE
Descriptive Title of What You're Doing
|
|
KEVIN
Weekly meeting: Second life
Each sectional members are now put on the spot for weekly updates, so we get more in-depth look at each accomplishments.
|
|
MANDY
Descriptive Title of What You're Doing
|
|
PATRICK
Descriptive Title of What You're Doing
|
|
PRIMA
Descriptive Title of What You're Doing
|
|
STEFAN
Robots!
Yesterday, time was spent on building a robot (Biobert) that will act
as a guide to our lab and also the rest of the island. It had to be
built from scratch because the first one wasn't very good and creeped
people out because it transformed from a pipette and had an empty
soulless expression. Once it was built, Mandy added the script so it
could talk to people (including several secret phrases!). I designed
it to move its arms and mouth when touched and optimized to use the
least prims possible in order to make sure we have enough left for
other things on the island. Today, a second robot was also made in the
same fashion (Synthia) because Biobert was lonely and she needed a
friend.
|
|
VICKI
Descriptive Title of What You're Doing
WIKI CODING GOES HERE
|